罕见病研究 (Jan 2022)

Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)

  • Rare Diseases Society of Chinese Research Hospital Association,
  • China Alliance for Rare Disease,
  • Beijing Society of Rare Disease Clinical Care and Accessibility,
  • Gitelman Syndrome Consensus Working Group

DOI
https://doi.org/10.12376/j.issn.2097-0501.2022.01.010
Journal volume & issue
Vol. 1, no. 1
pp. 56 – 67

Abstract

Read online

In recent years, research on the clinical phenotypes, new classifications, modified functional tests, biomarkers and management experience for patients with Gitelman syndrome (GS)has made a lot of progress in China. Based on evidence-based medicine, this consensus summarizes aspects related to GS, including clinical manifestations and classification, diagnosis, treatment strategies, and management of chronic complica-tions and comorbidity. This consensus provides an important reference for the diagnosis and treatment of GS.

Keywords